MNHS researchers awarded $7.5million in NHMRC Centres of Research Excellence funding
The Federal Government has today announced $7.5 million in funding for three National Health and Medical Research Council (NHMRC) Centres of Research Excellence led by Monash Medicine Nursing and Allied Health researchers.
The Centres of Research Excellence (CRE) scheme provides support for teams of researchers to pursue collaborative research and develop capacity in basic science research, clinical research, health services research and public health research, with the objective to improve health outcomes and promote or improve translation of research outcomes into policy and practice.
The CREs announced for funding today were the highest ranking from a competitive field of applications as assessed by panels of expert peers.
One of the new funding allocations will enable the continuation of SPHERE CRE, a centre with an established history of driving better sexual and reproductive health outcomes for women through primary care, led by Professor Danielle Mazza AM from the School of Public Health and Preventive Medicine. Two new centres will investigate a hidden and neglected cause of hypertension and optimise immunoglobulin management, led by Professor Peter Fuller from the Hudson Institute of Medical Research and Professor Erica Wood AO from the School of Public Health and Preventive Medicine respectively.
Deputy Dean of Research Professor James Whisstock welcomed the announcement. “NHMRC funding is prestigious and highly competitive, so I’m delighted to hear of our success in the 2023 funding round. Best wishes to our researchers as they pursue these three vital research endeavours.”
See below for the full details of the funded projects.
SPHERE 2.0 - The Centre of Research Excellence in Women's Sexual and Reproductive Health in Primary Care
Professor Danielle Mazza AM, School of Public Health and Preventive Medicine
Australia’s 6 million women of reproductive age continue to struggle with accessing high-quality care to optimise their health prior to pregnancy, prevent unplanned pregnancy or terminate a pregnancy when desired or required. The aim of SPHERE 2.0 is to increase access to high-quality, patient-centred sexual and reproductive health care so that women in Australia can achieve bodily autonomy and have the number of children they want when they want them.
Primary Aldosteronism Centre of Excellence (PACE): optimising the diagnosis and management of a common, curable but neglected cause of hypertension
Professor Peter Fuller, Hudson Institute of Medical Research and School of Clinical Sciences at Monash Health
Primary aldosteronism (PA) is a hidden cause of high blood pressure known to cause stroke, irregular heartbeat and heart attack. It is caused by excessive production of aldosterone from the adrenal glands and is potentially curable. Our goal is to find over half a million patients with high blood pressure caused by undiagnosed PA. We will revamp guidelines, develop better tests and train doctors to ensure that every patient in Australia has the opportunity for optimal diagnosis and treatment.
OPTIMAL: OPTimising Immunoglobulin Management in Australia
Professor Erica Wood, School of Public Health and Preventive Medicine
Immunoglobulin products, made from donated plasma, are precious (and costly) national resources. How best to use them for individual patients, and patient preferences on how immunoglobulin therapy is delivered, are not known. We will study how care is currently delivered and provide resources to improve it, by understanding current use and costs, asking people their values and preferences, and designing and introducing clinical guidelines and better models of care to help meet their needs.
For more information about the NHMRC Centres of Research Excellence, visit their website.
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.